3 Firms Lead $2.8B Merger Of Cancer Treatment Developers
Exact Sciences Corp. has agreed to a roughly $2.8 billion merger with fellow cancer treatment developer Genomic Health Inc., the companies said Monday, in a deal stitched together by Skadden, Sullivan...To view the full article, register now.
Already a subscriber? Click here to view full article